Please use this identifier to cite or link to this item: https://doi.org/10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704>3.0.CO;2-N
DC FieldValue
dc.titleAntibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma a new serologic parameter for diagnosis
dc.contributor.authorFeng, P.
dc.contributor.authorChan, S.H.
dc.contributor.authorSoo, M.Y.R.
dc.contributor.authorRen, E.C.
dc.contributor.authorHu, A.
dc.contributor.authorLiu, D.
dc.contributor.authorGuan, M.
dc.date.accessioned2012-03-28T06:04:07Z
dc.date.available2012-03-28T06:04:07Z
dc.date.issued2001
dc.identifier.citationFeng, P.,Chan, S.H.,Soo, M.Y.R.,Ren, E.C.,Hu, A.,Liu, D.,Guan, M. (2001). Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma a new serologic parameter for diagnosis. Cancer 92 (7) : 1872-1880. ScholarBank@NUS Repository. <a href="https://doi.org/10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704>3.0.CO;2-N" target="_blank">https://doi.org/10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704>3.0.CO;2-N</a>
dc.identifier.issn0008543X
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/31383
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704>3.0.CO;2-N
dc.sourceScopus
dc.subjectBRLF1 transcription activator
dc.subjectEnzyme linked immunosorbent assay
dc.subjectEpstein-Barr virus
dc.subjectNasopharyngeal carcinoma
dc.subjectSerologic test
dc.typeArticle
dc.contributor.departmentMICROBIOLOGY
dc.contributor.departmentGENOME INSTITUTE OF SINGAPORE
dc.description.doi10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704>3.0.CO;2-N
dc.description.sourcetitleCancer
dc.description.volume92
dc.description.issue7
dc.description.page1872-1880
dc.description.codenCANCA
dc.identifier.isiut000171476400016
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.